GH Research (GHRS) Non-Current Assets (2021 - 2025)

GH Research (GHRS) recorded quarterly Non-Current Assets of $134.2 million in Q4 2025, up 1756.21% quarter-over-quarter from $7.2 million in Q3 2025, and down 16.14% on a YoY basis from $160.1 million in Q4 2024.

GH Research (GHRS) Non-Current Assets (2021 - 2025) Analysis & Trends

GH Research's Non-Current Assets history runs 5 years deep, the most recent figure standing at $134.2 million for Q4 2025.

  • In Q4 2025, Non-Current Assets fell 16.14% year-over-year to $134.2 million; the TTM figure through Dec 2025 stood at $134.2 million (down 16.14% YoY), while the FY2025 annual figure was $134.2 million, down 16.14% from the prior year.
  • Non-Current Assets was $134.2 million for Q4 2025 at GH Research, up from $7.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $160.1 million in Q4 2024 to a low of $73000.0 in Q3 2021.
  • Historically, Non-Current Assets has averaged $55.6 million across 5 years, with a median of $55.6 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Non-Current Assets soared 104272.84% in 2023, then slumped 83.81% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $122.1 million in 2021, then decreased by 29.7% to $85.8 million in 2022, then decreased by 27.51% to $62.2 million in 2023, then soared by 157.3% to $160.1 million in 2024, then fell by 16.14% to $134.2 million in 2025.
  • The last three Non-Current Assets figures came in at $134.2 million (Q4 2025), $7.2 million (Q3 2025), and $19.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 62,953.78
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 289.41 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 4.56 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 30.30 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 14.75 Bn
9 Abivax 94.26 Bn 94.26 Bn - 39.71 Mn
10 GH Research 9.73 Bn 9.63 Bn - 134.24 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 134.24 Mn
Sep 30, 2025 7.23 Mn
Jun 30, 2025 19.55 Mn
Mar 31, 2025 25.79 Mn
Dec 31, 2024 160.07 Mn
Sep 30, 2024 44.67 Mn
Jun 30, 2024 54.07 Mn
Mar 31, 2024 57.11 Mn
Dec 31, 2023 62.21 Mn
Sep 30, 2023 68.53 Mn
Jun 30, 2023 73.87 Mn
Mar 31, 2023 84.54 Mn
Dec 31, 2022 85.82 Mn
Sep 30, 2022 84,000.00
Jun 30, 2022 86,000.00
Mar 31, 2022 81,000.00
Dec 31, 2021 122.08 Mn
Sep 30, 2021 73,000.00